Literature DB >> 25497348

Effects of the gut microbiota on bone mass.

Claes Ohlsson1, Klara Sjögren2.   

Abstract

The gut microbiota (GM), the commensal bacteria living in our intestine, performs numerous useful functions, including modulating host metabolism and immune status. Recent studies demonstrate that the GM is also a regulator of bone mass and it is proposed that the effect of the GM on bone mass is mediated via effects on the immune system, which in turn regulates osteoclastogenesis. Under normal conditions, the skeleton is constantly remodeled by bone-forming osteoblasts (OBs) and bone-resorbing osteoclasts (OCLs), and imbalances in this process may lead to osteoporosis. Here we review current knowledge on the possible role for the GM in the regulation of bone metabolism and propose that the GM might be a novel therapeutic target for osteoporosis and fracture prevention.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  gut microbiota; osteoimmunology; osteoporosis

Mesh:

Year:  2014        PMID: 25497348     DOI: 10.1016/j.tem.2014.11.004

Source DB:  PubMed          Journal:  Trends Endocrinol Metab        ISSN: 1043-2760            Impact factor:   12.015


  61 in total

Review 1.  The Microbiome and Osteosarcopenic Obesity in Older Individuals in Long-Term Care Facilities.

Authors:  Julia E Inglis; Jasminka Z Ilich
Journal:  Curr Osteoporos Rep       Date:  2015-10       Impact factor: 5.096

Review 2.  Nonalcoholic fatty liver disease and decreased bone mineral density: is there a link?

Authors:  G Targher; A Lonardo; M Rossini
Journal:  J Endocrinol Invest       Date:  2015-05-24       Impact factor: 4.256

Review 3.  [Gut microbiota and osteoporosis].

Authors:  Yong-Quan Huang; Tao Jiang; Hai-Tao Su; Yi-Wen Luo; Qiu-Ke Hou
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2016-02-20

Review 4.  The Potential of Probiotics as a Therapy for Osteoporosis.

Authors:  Fraser L Collins; Naiomy D Rios-Arce; Jonathan D Schepper; Narayanan Parameswaran; Laura R McCabe
Journal:  Microbiol Spectr       Date:  2017-08

5.  Lactobacillus rhamnosus JYLR-005 Prevents Thiram-Induced Tibial Dyschondroplasia by Enhancing Bone-Related Growth Performance in Chickens.

Authors:  Fang Liu; Anan Kong; Pengfei Fu; Qin-Qin Cao; Kun-Sheng Tao; Di-Yi Liu; Xue-Bing Wang; Zong-Xi Tong; Mujeeb Ur Rehman; Shu-Cheng Huang
Journal:  Probiotics Antimicrob Proteins       Date:  2021-02       Impact factor: 4.609

Review 6.  Autoimmunity, inflammation, and dysbiosis mutually govern the transition from the preclinical to the clinical stage of rheumatoid arthritis.

Authors:  Alexander Kalinkovich; Gulzan Gabdulina; Gregory Livshits
Journal:  Immunol Res       Date:  2018-12       Impact factor: 2.829

7.  Glycomacropeptide is a prebiotic that reduces Desulfovibrio bacteria, increases cecal short-chain fatty acids, and is anti-inflammatory in mice.

Authors:  Emily A Sawin; Travis J De Wolfe; Busra Aktas; Bridget M Stroup; Sangita G Murali; James L Steele; Denise M Ney
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2015-08-06       Impact factor: 4.052

8.  Selective protein depletion impairs bone growth and causes liver fatty infiltration in female rats: prevention by Spirulina alga.

Authors:  C Fournier; R Rizzoli; K Bouzakri; P Ammann
Journal:  Osteoporos Int       Date:  2016-06-25       Impact factor: 4.507

9.  Warmth Prevents Bone Loss Through the Gut Microbiota.

Authors:  Claire Chevalier; Silas Kieser; Melis Çolakoğlu; Noushin Hadadi; Julia Brun; Dorothée Rigo; Nicolas Suárez-Zamorano; Martina Spiljar; Salvatore Fabbiano; Björn Busse; Julijana Ivanišević; Andrew Macpherson; Nicolas Bonnet; Mirko Trajkovski
Journal:  Cell Metab       Date:  2020-09-10       Impact factor: 27.287

Review 10.  Probiotics in Gut-Bone Signaling.

Authors:  Jonathan D Schepper; Regina Irwin; Jun Kang; Kevin Dagenais; Tristan Lemon; Ally Shinouskis; Narayanan Parameswaran; Laura R McCabe
Journal:  Adv Exp Med Biol       Date:  2017       Impact factor: 2.622

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.